SSP for Lipitor® 10mg chewable tablets extended
The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Lipitor® 10mg chewable tablets (SSP032). SSP032 for Lipitor® 10mg chewable tablets was due to expire on 28 April but the end date has been further extended to Friday 12 May 2023.
The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Lipitor® 10mg chewable tablets (SSP032). SSP032 for Lipitor® 10mg chewable tablets was due to expire on 7 April but the end date has been further extended to Friday 28 April 2023.
The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Lipitor® 10mg chewable tablets (SSP032). SSP032 for Lipitor® 10mg chewable tablets was due to expire on 13 March but the end date has been further extended to Friday 7 April 2023.
The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Lipitor® 10mg chewable tablets (SSP032). SSP032 for Lipitor® 10mg chewable tablets was due to expire on 3 February but the end date has been further extended to Monday 13 March 2023.
The Department of Health and Social Care (DHSC) has reactivated SSP032 for Lipitor® 10mg chewable tablets and is currently set to expire on 3 February 2023.
The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Lipitor® 10mg chewable tablets (SSP032). SSP032 for Lipitor® 10mg chewable tablets was due to expire on 2 September 2022 but the end date has been further extended to Friday 9 September 2022.
The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocols (SSPs) for Lipitor® 10mg chewable tablets (SSP032). SSP032 for Lipitor® 10mg chewable tablets was due to expire on 26 August 2022 but the end date has been further extended to Friday 2 September 2022.
SSP032 – Lipitor® 10mg chewable tablets
SSP032 provides that for every Lipitor® 10mg chewable tablet originally prescribed, either one Atorvastatin 10mg film-coated tablet or the equivalent dose of Atorvastatin 20mg/5ml oral suspension sugar free must be supplied.
| For prescriptions (NHS or private) requesting: | Supply permitted under SSP032: | Current expiry date |
| Lipitor® 10mg chewable tablets | Atorvastatin 10mg tablets OR Atorvastatin 20mg/5ml oral suspension sugar free |
This SSP has been varied – the revised end date for SSP032 is now Friday 9 September 2022 |
Please note: expiry dates of an SSP may be brought forward or extended, and the content may be amended at any time during the life of an SSP. Pharmacists should ensure they are using the latest version of an SSP before considering the supply of an alternative product.
Current versions of SSPs can be found at: www.nhsbsa.nhs.uk/pharmacies-gp-practices-andappliance-contractors/serious-shortage-protocols-ssps
Support in implementing the SSPs
The following resources have been developed to support pharmacy teams in using these protocols.
Serious Shortage Protocols Operational Guidance
Serious Shortage Protocols Questions & Answers
PSNC’s Serious Shortage Protocols (SSPs) Endorsing Factsheet
PSNC Briefing 023/19: Serious Shortage Protocols – A guide for community pharmacy teams
Background information on SSPs
Further information on what SSPs are and when they may be used is available via the links below.
